Health care antiseptic product recalled for bacterial contamination
PeriGiene, a health care antiseptic manufactured by DermaRite Industries, is being recalled nationwide because the product was found contaminated with Burkholderia cepacia bacteria.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: FDA Class I classification establishes a minimum severity of Severe per the rubric. No illnesses or injuries are reported in the source, preventing a Critical classification.
Plain-English summary
DermaRite Industries is recalling PeriGiene, a health care antiseptic containing 0.5% Chloroxylenol, in 222 mL bottles. The affected product was distributed nationwide and includes multiple lot numbers with expiration dates ranging from November 2025 through January 2027. Approximately 5,703 bottles are affected by this recall.
The recall was initiated because the product was found to be contaminated with Burkholderia cepacia, a bacterium. The product is classified as non-sterile and should not contain this bacterial contamination.
The recalled product
- Product
- PeriGiene, Health Care Antiseptic, (Chloroxylenol 0.5%) 222 mL (7.5 fl. oz.) per bottle, DermaRite Industries LLC, 7777 West Side Avenue, North Bergen, NJ 07047. NDC 61924-198-08
- Manufacturer
- DermaRite Industries, LLC
- Category
- Drug — Healthcare Antiseptic
- Hazard
- bacterial-contamination
- burkholderia-cepacia
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (19)
- Lot #: 31013A
- Exp. Date 11/2025
- 40345A
- 40355A
- Exp. Date 4/2026
- 40571A
- 40580A
- Exp. Date 6/2026
- 40587A
- 40591A
- Exp. Date 7/2026
- 40870.1
- 40877.1
- Exp. Date 10/2026
- 41093A
- Exp. Date 12/2026
- 50072A
- 50079A
- Exp. Date 1/2027
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27